FGFR3 and achondroplasia: These strong evidences of FGFR3 implications in the RAS/MAPK signaling pathway along with our in silico results of the interactome, let us suggest that FGFR3 disorders (thanatophoric dysplasia, achondroplasia, and hypochondroplasia) may be included among the RASopathies.